SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Lalchandani Labs trades higher on the bourses

25 Jun 2018 Evaluate

Dr Lalchandani Labs is currently trading at Rs. 28.00, up by 0.50 points or 1.82% from its previous closing of Rs. 27.50 on the BSE.

The scrip opened at Rs. 28.00 and has touched a high and low of Rs. 28.00 and Rs. 28.00 respectively. So far 4000 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 30.15 on 24-May-2018 and a 52 week low of Rs. 23.30 on 15-May-2018.

Last one week high and low of the scrip stood at Rs. 28.95 and Rs. 27.50 respectively. The current market cap of the company is Rs. 11.92 crore.

The promoters holding in the company stood at 89.80%, while Non-Institutions held 10.20% stake in the company.

Dr Lalchandani Labs has entered into a lease agreement dated June 12, 2018 to set up a new Diagnostic and Processing Centre to be situated at 19C Club Road, Punjabi Bagh, New Delhi, as part of its expansion plans and to cater the vast diagnostic test needs of the customers located in that region. The company expects to begin the commercial operation from this Centre from the month of July, 2018.

Dr Lalchandani Labs is formed to set up, engage, collaborate, acquire, purchase, maintain, open collection centres, conduct, manage, administer, own, run laboratories for the purposes of carrying out pathological investigations of various branches of Bio-Chemistry, Hematology, Histopathology, Microbiology, Electrophoresis, Virology, Cytology, other pathological Investigations and Immunoassay, Immuno-Histochemistry, Molecular Pathology, DNA & Genetic Testing etc. 

Dr Lalchandani Labs Share Price

9.93 0.05 (0.51%)
20-Apr-2026 11:37 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×